Pancreatic Metastasis of Clear Cell Renal Cell Carcinoma: Challenges in Percutaneous Biopsy and Contrast‐Enhanced Ultrasound Imaging Features
Cancer Medicine · 2026-07 · 15 (7)
DOI: 10.1002/cam4.72123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 14.07.2026. Verfasst von Yang Gui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Pancreatic Neoplasms, Kidney Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Objectives
The objective of this study is to investigate the value of conventional ultrasound, contrast‐enhanced ultrasound (CEUS) and percutaneous ultrasound‐guided biopsy in the diagnosis of pancreatic metastases from clear cell renal cell carcinoma (ccRCC).
Methods
A retrospective database search was conducted to identify all pancreatic lesions performed CEUS and final diagnosed as metastasis from ccRCC at our institution from September 2017 to June 2024. All enrolled patients were considered unsuitable for endoscopic ultrasound (EUS)‐guided tissue acquisition, had failed EUS‐guided biopsy, or required an alternative diagnostic approach. A total of 23 patients were enrolled in this study. Demographics, clinical features, ultrasound and CEUS findings, biopsy procedures, and results were collected and reviewed.
Results
Of the enrolled patients, metachronous metastasis was 100%. The median interval time from tumor‐nephrectomy to the emergence of the pancreatic metastasis was 121.0 months (range: 46.0–276.0 months). Ultrasonography revealed rounded, well‐defined, homogeneous hypoechogenic lesions in all the patients. Color Doppler flow image findings displayed plenty of blood flow signals around and inside the pancreatic lesions in 87.0% of patients. 22 patients (95.7%) exhibited rapid hyper‐enhancement in the arterial phase of CEUS and 1 patient (4.3%) showed iso‐enhancement. In the venous phase, 15 cases showed sustained hyper‐enhancement and 8 cases showed iso‐enhancement. In the biopsy procedure, ultrasound‐guided core needle biopsy demonstrated higher diagnostic yield than fine needle aspiration (75.0% vs. 46.7%). The biopsy diagnosis was positive in 13 patients (65.0%) in general.
Conclusions
Metastatic tumors of the pancreas can occur after a prolonged period from ccRCC diagnoses, thus long‐term follow‐up is necessary. The features of the lesion by conventional ultrasound and CEUS were specific, which are valuable for diagnosis. In patients who are unsuitable for EUS‐guided tissue acquisition or have experienced unsuccessful EUS‐guided sampling, CEUS combined with percutaneous ultrasound‐guided biopsy may serve as a valuable complementary second‐line diagnostic approach and facilitate accurate diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Medical Oncology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Yang Gui, Ke Lv, Menghua Dai, Xiaoyan Chang, Xueqi Chen, Weibin Wang
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Gui, Y., Yan, X., Lv, K., Zhang, Z., Tan, L., Dai, M., Chang, X., Chen, X., Jia, W., Wang, W., & Jiang, Y. (2026). Pancreatic Metastasis of Clear Cell Renal Cell Carcinoma: Challenges in Percutaneous Biopsy and Contrast‐Enhanced Ultrasound Imaging Features. Cancer Medicine, 15(7). https://doi.org/10.1002/cam4.72123
Vancouver
Gui Y, Yan X, Lv K, Zhang Z, Tan L, Dai M, et al. Pancreatic Metastasis of Clear Cell Renal Cell Carcinoma: Challenges in Percutaneous Biopsy and Contrast‐Enhanced Ultrasound Imaging Features. Cancer Medicine. 2026;15(7). doi:10.1002/cam4.72123
BibTeX
@article{Gui2026,
author = {Gui, Yang and Yan, Xiaoyi and Lv, Ke and Zhang, Zhiyang and Tan, Li and Dai, Menghua and Chang, Xiaoyan and Chen, Xueqi and Jia, Wanying and Wang, Weibin and Jiang, Yuxin},
title = {Pancreatic Metastasis of Clear Cell Renal Cell Carcinoma: Challenges in Percutaneous Biopsy and Contrast‐Enhanced Ultrasound Imaging Features},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {7},
doi = {10.1002/cam4.72123}
}
EUVIMED